The regenerative medicine industry is expanding at an undeniably rapid clip. Advances in cell and gene technologies, tis...
Underscoring the critical role of sleep in diabetes prevention, investigators from the Global Centre for Asian Women&rsq...
Identifying therapeutic gene targets is essential for advancing personalised medicine and addressing the genetic basis o...
US-based biotech firm Indaptus Therapeutics, Inc. has secured new patent approvals in China, Japan and Israel for its De...
Callio Therapeutics, a Singapore and US-based biotechnology startup focused on realising the promise of multi-payload an...
A peer-reviewed paper detailing the experimental cancer treatment developed by Professor Georgina Long AO, Universi...
Which products are currently under development? 2025 will be a defining year for Caliway as we push ahead with key clin...
Japan-headquartered pharmaceutical firm Eisai has entered into an exclusive license agreement with a subsidiary of SciCl...
US-based startup HBM Alpha Therapeutics (HBMAT), Inc., an innovative biotechnology company incubated by China-based Harb...
Israel-based CollPlant Biotechnologies, a regenerative and aesthetics medicine company developing innovative technologie...
Researchers from the National University of Singapore (NUS) have pioneered a new catalytic transformation that converts ...
Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufactur...
Scientists at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) have developed a grou...
Sequential Skin, a world leader in skin microbiome testing, and AMILI, a leading expert in gut microbiome science, have ...
A new breast cancer therapy shown to significantly reduce the risk of cancer recurrence and improve disease-free surviva...
India-based Zydus Lifesciences (including its subsidiaries and affiliates), has signed an exclusive development, licensi...
In a breakthrough for the advanced study of gut health, scientists at the National University of Singapore (NUS) have de...
The first clinical consensus statement for managing multiple sclerosis (MS) in Australia and New Zealand has been releas...
